Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuyan Decoction is a Traditional Chinese Medicine (TCM) decoction currently undergoing investigation in a randomized controlled trial for the treatment of ulcerative colitis, specifically in patients presenting with spleen deficiency and dampness-blocking syndrome during the remission period. As a TCM decoction, it is composed of multiple herbal ingredients, and its therapeutic effects are generally understood to arise from the synergistic action of these components on various biological pathways. While the precise mechanism of Xuyan Decoction is not fully elucidated, TCM decoctions for ulcerative colitis typically aim to reduce inflammation, modulate immune responses, and improve gut barrier function through multi-target interventions. The clinical trial is being run by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xuyan Decoction.